Chief Medical Officer
BrightView Health, Michigan
R. Corey Waller MD, MS, FACEP, DFASAM is a board-certified and actively practicing addiction and emergency medicine specialist with extensive experience working at the local, state, and national levels. He has works with the American Society of Addiction Medicine (ASAM) and related organizations to advance the evidence-based practice of treatment and recovery for individuals affected by substance use disorder (SUD). A nationally recognized expert in SUD, he is now the Editor in Chief of The ASAM Criteria.
As a principal at the HMA Institute on Addiction, he is directly responsible for consultation regarding addiction treatment system development for hospitals, primary care practices, just involved populations, and addiction treatment providers. He oversees the HMAedu.com learning management system and continues to develop education covering addiction, pain, behavioral health, and the administrative support for those systems.
In his prior role as senior medical director for education and policy at the National Center for Complex Health and Social Needs, Dr. Waller was responsible for developing and maintaining all training and in-person technical assistance delivered by the National Center. This covered addiction, pain, behavioral health treatment system development, correctional medicine, payment model implementation, and healthcare policy.
Before joining the National Center, he worked for the Spectrum Health System in Grand Rapids, Michigan, a fully integrated health system with 14 hospitals and more than 1,000 employed physicians. Dr. Waller served as medical staff chief of pain medicine to the Spectrum Health Hospital System and medical director of the Spectrum Health Medical Group Center for Integrative Medicine, where he was responsible for treating patients with addiction, including management of pregnant mothers with substance use disorders. Additionally, he oversaw the development of core competencies for addiction treatment in the labor and delivery unit and the neonatal abstinence syndrome treatment algorithm for the Level 1 neonatal intensive care unit.
Disclosure information not submitted.
Friday, April 1, 2022
3:00 PM – 4:00 PM ET
Saturday, April 2, 2022
4:30 PM – 5:30 PM ET
